USFDA concludes surveillance inspection at API unit of Kopran’s arm

29 Apr 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has concluded surveillance inspection at API unit of Kopran’s wholly owned subsidiary -- Kopran Research Laboratories. The said API unit located at Mahad in Maharashtra. The inspection was conducted from April 21, 2025 to April 25, 2025. The inspection was concluded without any observations.

Kopran is engaged primarily in pharmaceuticals business. The Company manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.

Kopran Share Price

135.60 -4.10 (-2.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×